Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$0.16 - $1.64 $9,633 - $98,741
60,208 Added 153.8%
99,356 $17,000
Q2 2022

Aug 15, 2022

SELL
$0.51 - $0.93 $115,023 - $209,748
-225,536 Reduced 85.21%
39,148 $27,000
Q1 2022

May 13, 2022

BUY
$0.84 - $1.71 $15,964 - $32,498
19,005 Added 7.74%
264,684 $222,000
Q3 2021

Nov 16, 2021

BUY
$1.69 - $2.89 $77,337 - $132,252
45,762 Added 22.89%
245,679 $593,000
Q2 2021

Aug 16, 2021

BUY
$2.64 - $6.32 $462,963 - $1.11 Million
175,365 Added 714.26%
199,917 $528,000
Q1 2021

May 17, 2021

BUY
$1.35 - $4.99 $33,145 - $122,514
24,552 New
24,552 $123,000

Others Institutions Holding SEEL

# of Institutions
1
Shares Held
40.5K
Call Options Held
0
Put Options Held
0

About SEELOS THERAPEUTICS, INC.


  • Ticker SEEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 106,691,000
  • Market Cap $32M
  • Description
  • Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...
More about SEEL
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.